Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2012
07/12/2012WO2012056177A3 Use of sic particles for visualizing proteins and nucleic acids
07/12/2012WO2012054641A3 Hydrodynamic particle separation and detection systems and methods
07/12/2012WO2012048339A3 Selective detection of neisseria meningitidis
07/12/2012WO2012047889A3 Systems and methods for automated reusable parallel biological reactions
07/12/2012WO2012040168A3 Biomarkers for differentiating melanoma from benign nevus in the skin
07/12/2012WO2012030786A3 Canine bocavirus sequences and uses thereof
07/12/2012WO2012027469A3 Antimicrobial method for fermentation processes
07/12/2012WO2012016215A3 Microbial bioindicators of hydrocarbons in water and in marine sediments and methods for making and using them
07/12/2012WO2011146531A9 Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (rtca) cardio instruments
07/12/2012WO2011143659A3 Nucleic acid isolation methods
07/12/2012WO2009152529A8 Programming and reprogramming of cells
07/12/2012US20120180149 Double mutant mouse and cell lines
07/12/2012US20120180147 Microrna-24
07/12/2012US20120179014 Device and method for determining analyte levels
07/12/2012US20120178912 RECEPTOR ACTIVATOR OF NF-kappaB
07/12/2012US20120178911 Genes with es cell-specific expression
07/12/2012US20120178796 Splice variants
07/12/2012US20120178791 MODULATION OF HUMAN CYTOMEGALOVIRUS REPLICATION BY MICRO-RNA 132 (miR132), MICRO-RNA 145 (miR145) AND MICRO-RNA 212 (miR212)
07/12/2012US20120178784 Use Of Inhibitors Of The Renin-Angiotensin System
07/12/2012US20120178773 Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
07/12/2012US20120178772 Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
07/12/2012US20120178757 Method For The Prevention Of Cancer Metastasis
07/12/2012US20120178749 Ns1 protein inhibitors
07/12/2012US20120178719 Modulation of phospholipase d for the treatment of neurodegenerative disorders
07/12/2012US20120178690 Novel netrin derivatives and uses thereof
07/12/2012US20120178645 Identifying circulating tumor cells (ctcs) using cd146 in breast cancer patients
07/12/2012US20120178644 Gene expression profiling of egfr positive cancer
07/12/2012US20120178639 Bionanosensor detection device
07/12/2012US20120178634 Method for determination of presence of cancer cell, and method for determination of prognosis of cancer patient
07/12/2012US20120178633 Diagnostic composition for autoimmune diseases comprising agent measuring cd3z gene methylation level and a method for diagnosing autoimmune diseases using the same
07/12/2012US20120178632 Biomarkers for identifying patient classes
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120178157 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/12/2012US20120178122 Apparatus and method for analyzing bacteria
07/12/2012US20120178121 Method to characterize blood and red blood cells via erythrocyte membrane fragility quantification
07/12/2012US20120178120 Microplate
07/12/2012US20120178119 Method for measuring autophagy
07/12/2012US20120178116 Polypeptides for identifying fungicidally active compounds
07/12/2012US20120178115 Mutants of Pyrroloquinoline Quinine-Dependent Soluble Glucose Dehydrogenase
07/12/2012US20120178114 Methods and devices for detecting thrombin generation
07/12/2012US20120178099 Highly fluorescent carbon nanoparticles and methods of preparing the same
07/12/2012US20120178097 Methods and design of membrane filters
07/12/2012US20120178096 Method for isolating weakly interacting molecules from a fluidic sample
07/12/2012US20120178095 Cardiomyocyte differentiation
07/12/2012US20120178094 Method for Categorizing Circulating Tumor Cells
07/12/2012US20120178093 Methods of assessing a risk of cancer progression
07/12/2012US20120178092 Method for the Replication, Amplification or Sequencing of a DNA Template
07/12/2012US20120178091 Assay Cartridges and Methods of Using the Same
07/12/2012US20120178090 Method for isolating nucleic acids and protein from a single sample
07/12/2012US20120178089 Materials and methods for the identification of drug-resistant cancers and treatment of same
07/12/2012US20120178088 The tumor suppressor killin
07/12/2012US20120178087 Genotyping Assay to Predict Gamma Glutamyl Hydrolase (GGH) Activity
07/12/2012US20120178085 Method for evaluation of cultured cells, and method for screening of biomarker
07/12/2012US20120178084 Integrated active flux microfluidic devices and methods
07/12/2012US20120178083 SPECIFIC MARKER Lmx1a ON DOPAMINERGIC NEURONS
07/12/2012US20120178082 Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
07/12/2012US20120178080 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
07/12/2012US20120178079 Human Bocavirus and Methods of Diagnosis and Treatment
07/12/2012US20120178078 Methods and Compositions for Nucleic Acid Detection
07/12/2012US20120177782 Soy milk fermentation
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177676 Alphabodies for hiv entry inhibition
07/12/2012US20120177665 Method of diagnosing and treating interstitial cystitis
07/12/2012US20120177661 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor
07/12/2012US20120177659 Methods and compositions for treating and diagnosing diseases
07/12/2012US20120177641 Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto
07/12/2012US20120177632 Methods of optimizing disease treatment
07/12/2012US20120177611 Elastic substrates and methods of use in cell manipulation and culture
07/12/2012US20120177599 Compositions and methods for treatment, diagnosis and prognonis of mesothelioma
07/12/2012US20120177581 Bystander immune suppression as a predictor for response to a vaccine
07/12/2012US20120177566 Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells
07/12/2012DE102011076221B3 Automatisierter CTC Nachweis Automated detection of CTC
07/12/2012DE102010037622B4 Verfahren zum Nachweis, Differenzieren und Quantifizieren von T-Zellpopulationen mittels der Reverse Transkription quantitativen Real-Time PCR (RT-qPCR) Technologie Methods for detection, differentiation and quantification of T cell populations by means of reverse transcription quantitative real-time PCR (RT-qPCR) technology
07/12/2012DE102010000906B4 Konjugate für den Nachweis doppelsträngiger Nukleinsäuren Conjugates for the detection of double-stranded nucleic acids
07/12/2012CA2832403A1 System for and method of determining cancer prognosis and predicting response to therapy
07/12/2012CA2824419A1 Scn5a splice variants for use in methods relating to sudden cardiac death and need for implanted cardiac defibrillators
07/12/2012CA2824404A1 Assay cartridges and methods of using the same
07/12/2012CA2824043A1 Esophageal cytokine expression profiles in eosinophilic esophagitis
07/12/2012CA2823876A1 Viral diagnostics
07/12/2012CA2823627A1 Materials and method for genotyping and quantifying a high-risk human papillomavirus
07/12/2012CA2823618A1 Noninvasive prenatal genotyping of fetal sex chromosomes
07/12/2012CA2822950A1 Gene and variations associated with bm1 phenotype, molecular markers, and their use
07/11/2012EP2474830A1 Method for determining Factor XIII deficiencies using thromboelastographic techniques
07/11/2012EP2474825A1 Sensor and concentration measurement method
07/11/2012EP2474822A1 Methods of predicting mortality risk by determining telomere length
07/11/2012EP2474632A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
07/11/2012EP2474631A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
07/11/2012EP2474630A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
07/11/2012EP2474629A1 New markers for cancer
07/11/2012EP2474628A1 New markers for cancer
07/11/2012EP2474627A1 New markers for cancer
07/11/2012EP2474626A2 Detecting neoplasm from a stool sample
07/11/2012EP2474625A1 Response prediction in cancer treatment
07/11/2012EP2474624A1 Response prediction in cancer treatment (p53 adapted cancer therapy)
07/11/2012EP2474623A1 Compositions and methods for therapy and diagnosis of cancer and cancer metastasis
07/11/2012EP2474622A1 Method for the diagnosis and/or prognosis of acute renal damage
07/11/2012EP2474621A1 Markers for selecting personalised cancer treatment therapies
07/11/2012EP2474620A1 Method for removing high density lipoprotein in blood
07/11/2012EP2474616A1 Methods and compositions involving microRNA
07/11/2012EP2473855A1 Use of cathepsin h